OUHSC Research News – Monday, November 21, 2022
Published: Friday, November 18, 2022
OUHSC Research News – Monday, November 21, 2022
Notices and Reminders
In alignment with the University’s closure for the upcoming holidays, the Office of the Vice President for Research (VPR) will be closed for:
Thanksgiving Break – The Office of the VPR including ORA will be closed Thursday, November 24, 2022 and Friday, November 25, 2022, reopening on Monday, November 28, 2022.
Winter Break – The Office of the VPR including ORA will be closed on December 23, 2022 through January 2, 2023, reopening on January 3, 2023.
Any proposals or other items due to sponsors during this time must be submitted to ORA within three business days before the campus closure dates. Any contracts expiring December 30, 2022 need to be in our office by December 12, 2022. Should you need urgent assistance during the holiday closure, please contact ORA at HSCORA@ouhsc.edu. All other matters will be addressed when the University reopens for regular business hours.
Guidance for Collecting Demographic Diversity Data via Survey
In 2019 the National Institutes of Health (NIH) released the “Notice of NIH's Interest in Diversity” that identified populations that should be prioritized to ensure national scientific workforce diversity goals are achieved. To achieve this aim, identified offices on campus, including the Offices of Diversity, Equity, and Inclusion (DEI) and Institutional Research (IR), collaborate to understand the diversity attributes (ethnicity, disadvantaged status, disability status, etc.) of HSC faculty, staff, and students. These activities inform a number of functions including institutional planning, decision-making, and external reporting efforts. Reports on these data attributes are often included as a component of required annual reporting, as an example, or may be considered necessary in certain applications. In many cases, these data are available from the University already and need not be surveyed again. Prior to conducting your survey, please confirm with the DEI and IR offices to see if the data you need, or reliable proxy measures, are already available.
In cases where data collection is necessary, please adhere to the following guidelines to ensure your data collection activities result in valid, complete, and properly aggregated data:
- Include procedures to maintain the anonymity and confidentiality of survey respondents.
- Make clear to survey recipients that their participation is voluntary and they are free to not participate.
- Ensure that responses cannot be traced back to respondents.
- Ensure that no personally identifiable information is captured.
- Survey instruments that are a component of an Institutional Review Board (IRB) approved research study don’t require further review.
If your survey instrument does not meet the exclusion criterion but you believe it needs to collect identifiable information, please contact the office of DEI at Diversity-Inclusion@ouhsc.edu.
You will be contacted to discuss your request and clarify the specific information you need. Please allow at least 3 business days for the completion of your request.
Workshops and Seminars
The Office of Technology Commercialization Lunch and Learn - Federal Reporting/NDAs & MTAs
Date/Time: Wednesday, November 30, 2022 12:00 p.m. (CDT)
Why you Do Need an MTA, NDA, or DUA and IP Reporting Requirements?
I am asked many times: Why do we need an MTA or an NDA or a DUA?
The short answer is: To support AND protect your Research.
The next question is: Why does it matter if IP results or not?
The short answer is: Reported IP continues to support Additional Research.
- Why you do need an MTA or an NDA or a DUA.
- All these agreements support AND protect your Research.
- Federal funding is great support for your Research and IP continues to support future Research.
- Inventions and Patents which result from Federally funded Research have reporting requirements.
How can we make sure to address those regulatory requirements and keep Research on all OU campuses active?
Registration link: Space is limited, so participants must register.
Office of Technology Commercialization Website: ou.edu/otc
Free Workshop - IDeA National Resource for Quantitative Proteomics
On December 6, 2022, the Oklahoma INBRE and IDeA National Resource for Quantitative Proteomics are hosting a workshop describing the different proteomics methods available in the National Resource. One goal of the National Resource is to make advanced proteomics methods available to all Oklahoma scientists. Mike Kinter’s OMRF laboratory is a part of the resource along with Alan Tackett’s group at the University of Arkansas for Medical Sciences. The workshop will take place in the Conference Center at the Oklahoma Medical Research Foundation (OMRF). All Oklahoma scientists are invited. The workshop is free and includes lunch, but space is limited.
Registration is required but is done simply by emailing firstname.lastname@example.org. The deadline is Wednesday November 30. A flyer for the workshop is attached.
Registration Deadline: November 27, 2022
Description: OU Health Stephenson Cancer Center is proud to host the 2022 END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer conference from December 1-2, 2022 in Oklahoma City, Oklahoma, USA.
The END2CANCER conference will start the morning of December 1, 2022 and conclude in the afternoon of December 2, 2022. The conference will bridge laboratory research conducted in the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by eminent scientists who will discuss new and emerging concepts, technologies and challenges in translating nanomedicine from bench-to-bedside.
Topics to be discussed in the planned thematic sessions include Gene and Drug Delivery, Immuno-Oncology, Drug Discovery and New Drugs on the Horizon for Clinical Translation, Extracellular Vesicles, Combinatorial Therapeutics, and more to come.
The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers, physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates, business professionals, educators and technology transfer specialists. Students and fellows will have an opportunity to present their work and compete for cash awards. We will again be hosting a special session titled "Art of Science in Light of Nanomedicine" will allow participants to display their best research as a photo with a caption and compete for a cash prize.
We will be hosting a reception and dinner at the Devon Boathouse on Dec. 1 from 6:30 to 9:30 p.m.
Please RSVP by Nov. 22 if you wish to attend: https://ousurvey.qualtrics.com/jfe/form/SV_07HhnSZxanlky3A
The National Symposium on Sexual Behavior of Youth Call for Poster Abstracts
Description: Join your colleagues on Wednesday, February 22, 2023 from 5:00p - 7:00p for the multi-disciplinary NSSBY poster session that will highlight the latest research, programs, and activities in the field. Light snacks will be available during the poster session, which will be concurrent with the Welcome Reception. The poster session provides opportunities for extended discussion with symposium participants about your work.
Poster submissions must be received by November 30, 2022. Announcements of acceptance will be made by December 15, 2022.
Posters describing innovative programs and implementation strategies are encouraged and welcomed. Posters can focus on a wide variety of topics related to the sexual behavior of youth, such as:
- sexual development
- sex education
- healthy sexual behavior
- impact of technology
- problematic/harmful and/or illegal sexual behavior
- long-term outcomes
More information can be found at: https://connect.ncsby.org/nssby2023/call-for-proposals/posters
OUHSC Funding Opportunities
Call for Applications: PHF Equipment, Symposium, and Seed Grant Programs
November 30, 2022
November 30, 2022
December 2, 2022
Presbyterian Health Foundation (PHF) Equipment Grant Program – Request For Applications
- Cycle I PHF Equipment Grant Program Deadline: November 30, 2022
The primary objective of the PHF Equipment Grant program is to provide partial funding for critically needed research equipment. Funding priority will be given to research equipment that will permit OUHSC investigators to be more competitive for external funding and provides support to multiple users. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) All Assistant, Associate, or Full Professors are eligible to apply.; 2) Principal investigators with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes, such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Requests should be sent to ORA4PHF@ouhsc.edu.; 3) PHF Equipment Grant recipients may hold any other PHF Grant award simultaneously, except for a Clinician Scientist Development Award.
Presbyterian Health Foundation (PHF) Symposium Grant Program – Request For Applications
- Cycle I PHF Symposium Grant Program Deadline: November 30, 2022
The primary objective of the PHF Symposium Grant program is to provide partial funding to support a National or International Symposium to be held at the OUHSC campus or in Oklahoma City. Funding priority will be given to themes that will promote research already present at OUHSC and OMRF and include both OUHSC faculty members and OMRF members in the Organization Committee. OUHSC Principal Investigators are eligible to apply if they meet the following criteria: 1) The Principal Investigator of the application must be the Chair of the Organizing Committee. Only OUHSC full-time, tenure-track faculty members (unmodified titles) are eligible to be PIs. 2). The PI may hold any other PHF Grant award, except for a Clinician Scientist Development Award.
Presbyterian Health Foundation (PHF) Seed Grant Program – Request For Applications
- Cycle I PHF Seed Grant Program Deadline: December 2, 2022
The primary objective of the PHF Seed Grant program is to provide a one-year grant for new OUHSC investigators to initiate research programs. Secondary objectives are to provide established OUHSC faculty with the opportunity to initiate new unfunded projects and to provide unfunded OUHSC faculty funds to initiate a research program. Applications from new investigators (within 5 years of first full academic appointment and never having received independent federal funds) are given special consideration during peer review and at the time of funding consideration. Principal Investigators with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Approval will require a letter from their Department Chairperson indicating a departmental commitment of salary, research space, and time for development of an independent career at OUHSC. Requests should be sent to ORA4PHF@ouhsc.edu PHF Seed Grant recipients may not hold a PHF Bridge Grant or a PHF Clinician Scientist Development Grant during the duration of this award.
IMPORTANT UPDATE: This PHF Seed Grant program can now provide funding for up to $75,000 for one year. SALARY and FRINGE BENEFITS may be requested for the Principal Investigator(s) up to $25,000 in total (salary + fringe benefits = $25,000) with the remaining portion, $50,000, used to support the project costs.
Guidelines and Application Forms are attached or can be found at https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email VPR@ouhsc.edu.
Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email email@example.com or firstname.lastname@example.org).
- Johnson & Johnson is seeking innovative solutions to create sustainable premium packaging. Approaches of interest include coating techniques to provide metallic luster to existing plastic packaging products, nanotechnology surface treatments and novel materials for packaging that provide a premium quality appearance and sustainable manufacturing methods. Out of scope: coatings that apply a dark color and hazardous materials. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information. (deadline 12/22).
- A world-leader in vaccine manufacturing is seeking research linking viral or bacterial infection and chronic disorders in order to develop new treatments targeting microbial pathogens. In scope: biological approaches to prevent or reduce chronic disease, research relating to any chronic condition, provided there is a validated link with bacterial or viral infection. Out of scope: small molecule, enzyme therapy, gene therapy and cell therapy. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information. (deadline 12/22).
- Johnson Matthey is seeking research proposals to develop metal trapping materials for use in fluid catalytic cracking (FCC). Of particular interest are materials with highly efficient/stable trapping for iron and vanadium under high temperatures and steam and functional and deactivation mechanism of metal trapping materials under FCC conditions. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information. (deadline 12/22).
American Cancer Society Institutional Research Grant (ACS-IRG)
DEADLINE: Friday, December 16, 2022; Due by 5:00 PM
ACS-IRG funds provide $50,000 to new/early stage faculty with cancer research pilot projects
- ASSISTANT PROFESSOR or equivalent level position that holds a tenure- or research-track appointment on OUHSC, OU-Norman or OU-Tulsa campus and within SIX years of first independent academic appointment.
- Without CURRENT grant support from national funding agencies (e.g. NIH, DOD, NSF, ACS).
INSTRUCTIONS AND APPLICATION:
Application, Guidelines and more information can be found:
Application, Forms & Guidelines | SCC Website
For questions, please contact The SCC Office of Cancer Research
ASSISTANT PROFESSOR FACULTY POSITIONS: Cellular and Molecular GeroScience CoBRE
The Center for Geroscience and Healthy Brain Aging at the University of Oklahoma Health Sciences Center (OUHSC) invites exceptional scientists to apply for tenure-track eligible faculty positions. Applications from individuals with expertise in multiple research areas related to the biology of aging or to diseases associated with aging are requested. Areas of special interest include but are not limited to bioenergetics, metabolism, adult stem cells/tissue regeneration, cell signaling and mechanisms of neurodegeneration. The individual(s) selected will be appointed as Assistant Professor in a Basic Science Department at OUHSC and will join the NIA P20 Cellular and Molecular Geroscience CoBRE Program, from which they will receive substantial research funding while they apply for independent NIH funds. The start date will be during the Spring/Summer of 2023 at dates negotiated with successful applicants.
Minimum Qualifications and Requirements: Successful candidates are expected to develop innovative and externally funded research programs, participate in education programs, and contribute to university service. Candidates should have a PhD and/or MD and are expected to have significant postdoctoral research experience with the potential of developing a nationally recognized research program. The individuals should have Early Stage Investigator (ESI) status and not been awarded an independent NIH grant.
The Center for Geroscience and Healthy Brain Aging is a highly interactive group of scientists with interests in aging, brain aging, neurological diseases of aging, gero-oncology, developmental determinants of aging, metabolism, diabetes, and immunology. The Center for Geroscience is home to the NIA P30 Oklahoma Nathan Shock Center on Aging, the NIA T32 Geroscience Training Program and the NIA P20 Cellular and Molecular Geroscience CoBRE grant and receives over $10M in extramural funding annually. Successful applicants will receive a competitive salary, a multi-year start-up package, and be assigned newly renovated laboratory space.
Candidates should submit a Specific Aims page, an NIH Biosketch and a ½ page list of Future Directions as a single pdf file. Contact information for at least three references should be included. Please send the application packet to Melissa-K-Day@ouhsc.edu no later than Monday, December 12th, 2022. The applicant is expected to write a full CoBRE application that will be part of the Phase 2 CoBRE renewal due May 25, 2023, with the assistance of the leadership of the Center for Geroscience.
The University of Oklahoma and the Center for Geroscience have a commitment to diversity, equality, and inclusion. The University of Oklahoma Health Sciences Center is an equal employment opportunity and affirmative action institution http://www.ou.edu/eoo. Individuals with disabilities and protected veterans are encouraged to apply.
- AHRQ Announces Interest in Healthcare Associated Infections and Combating Antibiotic Resistant Bacteria Research
- This Notice is to expire PA-20-068 "Improving Quality of Care and Patient Outcomes During Care Transitions (R01)"
- Notice to Extend the Response Date for NOT-AR-22-023 "Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FYs) 2025-2029"
- Notice of Technical Assistance Webinar for Potential Applicants to RFA-CA-23-013, Transformative Educational Advancement and Mentoring Network (TEAM) (R25 Clinical Trial Not Allowed)
- Notice of a Question and Answer "Office Hour" with NIGMS Staff for IMSD and G-RISE Applicants
- Notice of Information on NIMH's Considerations for Research Involving Psychedelics and Related Compounds
- Showcase Opportunities for NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees
- Human Subjects Research: Policies, Inclusion, & Clinical Trials Free 2-Day Virtual Event with NIH & HHS Experts December 6-7, 2022
- Notice of Future Research Opportunity Announcement for All of Us Research Participant and Partner Services Center
- Request for Information: Soliciting Public Comment on Draft Amyotrophic Lateral Sclerosis (ALS) Strategic Plan
- Notice of NIAMS Participation in PAR-20-089, "Biomedical Data Repository (U24 - Clinical Trials Not Allowed)"
- Notice of NIAMS Participation in PAR-20-097, "Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)"
- Notice of Change to Application Due Dates and deletion of the Introduction to Application Section for RFA-DK-22-019
- Notice of Change in Page Limitations for PAR-22-194 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)"
- Notice of Intent to Publish a Funding Opportunity Announcement for NIH Brain Development Cohorts Biospecimen Access (X01 Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Entry-Level Modules (ELM) for Training the Genomics Research Workforce (UE5-Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)
- Notice of Intent to Publish a Funding Opportunity Announcement for Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)
- Notice of Special Interest (NOSI): Administrative Supplement for NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
- Notice of Special Interest (NOSI): Chemsex and HIV: prevalence, medical/psychosocial consequences, and treatment
- Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
NIH Funding Opportunities
- Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
Application Receipt Date(s): Multiple dates, see announcement.
- Cooperative Centers on Human Immunology (U19 Clinical Trial Optional)
Application Receipt Date(s): April 07, 2023
- NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)
Application Receipt Date(s): February 28, 2023
- NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required)
Application Receipt Date(s): February 28, 2023
- NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required)
Application Receipt Date(s): February 28, 2023
- HEAL Initiative: Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program (R01 Clinical Trial Optional)
Application Receipt Date(s): February 10, 2023
- HEAL Initiative - Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program: Leadership and Data Co-ordinating Center (U01 Clinical Trial Optional)
Application Receipt Date(s): February 10, 2023
- Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
Application Receipt Date(s): March 23, 2023
- Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)
Application Receipt Date(s): January 12, 2023
- Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed)
Application Receipt Date(s): January 12, 2023
- Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional)
Other Funding Opportunities
2023 GCRLE Grants Call for Applications
The Global Consortium for Reproductive Longevity and Equality (GCRLE) is soliciting 2-year grant applications aimed at identifying unifying principles that underlie female reproductive aging. Our goal is to facilitate ambitious projects and stimulate collaborations across disciplines that will help define the field of female reproductive longevity and empower women with parity and options in their reproductive choices. The awards are open to researchers based at both national and international accredited academic and nonprofit research institutions. We would greatly appreciate it if you could share this announcement with anyone you know who might be qualified or to your institution’s relevant grant officer. Details can be found on the application page when the application portal opens on November 18th, 2022.
Applications Due: The deadline to apply for this award is December 16th, 2022 at 11:59pm PST. All materials required will be found on the application portal at gcrle.org/apply when it opens.
The application process is designed to be straightforward with a simple 2-page proposal.
Specific Funding Mechanisms (2-year awards)
- Senior Scholar Awards fund established investigators who are thought leaders in their respective fields and are recognized for substantial contributions of creative and productive research to pursue substantive, innovative research in female reproductive aging. This award grants $400,000/year in funding.
- Junior Scholar Awards fund early career investigators with outstanding promise when they are establishing their own labs. These awards are to encourage young scientists to pursue bold ideas in female reproductive aging when they are at their most scientifically creative. This award grants $250,000/year in funding.
- Postdoctoral Fellowship Awards fund exceptional young scientists at the beginning of their postdoctoral training in the area of female reproductive aging, broadly defined. Our goal is to provide support and training to promising postdoctoral scholars and to encourage the next generation of researchers to pursue creative projects in this exciting, nascent field. This award grants $100,000/year in funding, $70,000 of which must be used for the Fellow’s salary.
- Pilot Awards fund pilot projects to foster innovative or novel research projects in female reproductive aging that have the potential for high impact and high reward at an accelerated rate. This award grants $100,000/year in funding.
For all funding mechanisms, we seek to complement other major funders of research by placing emphasis on projects that may not be supported by traditional sources because of their perceived novelty or high risk, or because the investigator is moving into female reproductive aging from a different research area. We look forward to your applications!
Cystic Fibrosis Foundation Call for Mental Health Research Working Group Members
Description: The mission of the Cystic Fibrosis Mental Health Research Working Group (MHRWG) is to advance our knowledge of mental health conditions in the CF population throughout the lifespan and promote clinical and translational research that will improve the understanding, prevention, diagnosis, and treatment of mental health concerns in CF. The MHRWG is seeking to create a multi-disciplinary group, including, but not limited to, physicians/psychiatrists, psychologists/neuropsychologists, social workers, pharmacists etc., and other specialists with an interest in CF mental health. Applications must be submitted online at awards.cff.org. For questions, please contact Dara Riva (email@example.com) and Kayli Davis (firstname.lastname@example.org).
Applications Due: December 14, 2022
Link to Full Announcement: https://www.cff.org/researchers/mental-health-research-working-group
Cystic Fibrosis Foundation Medical Resident Research Award
Description: The newly launched CF Foundation Medical Resident Research Award is designed to introduce residents to research through participation in a CF-relevant research project with the goal to develop and maintain interest in a career in CF research or as a CF care provider. Awards support up to $10,000 in salary or research related costs for one year and applications are accepted on a rolling basis at awards.cff.org. For questions, please contact Liz Yu (email@example.com).
Link to Full Announcement: https://www.cff.org/researchers/medical-resident-research-award
The Leona M. and Harry B. Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program
Description: The Leona M. and Harry B. Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program is launching a Request for Proposals (RFP) to support the development of novel, real-world solutions to help people with T1D exercise safely and to improve their quality of life. Researchers and clinicians are expected to partner with statistical teams to analyze the real-world data that was collected under Helmsley’s T1D Exercise Initiative (T1-DEXI), build collaborations with other necessary third parties, and to test their novel solutions in studies with people with T1D. The overarching purpose of this initiative is to move real-world data towards real-world solutions.
Concept Notes due: April 30, 2023
Link to Full Announcement: https://helmsleytrust.org/request_for_proposal/improving-exercise-with-type-1-diabetes-moving-data-towards-solutions/
Cystic Fibrosis Foundation Idea Development Award
Description: The Spring 2023 Idea Development Award (IDA) is intended to support work that leads to sufficient project development to enable an application for future research funding from the Cystic Fibrosis Foundation or the National Institutes of Health. For more information, visit the IDA webpage. For questions, please contact Dara Riva (firstname.lastname@example.org).
Applications Due: February 2, 2023
Link to Full Announcement: https://www.cff.org/researchers/idea-development-award